Geode Capital Management’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Geode Capital Management’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,475	Closed	-$360K	–	4750
2023 Q3	$360K	Buy	45,475 +10	+0%	+$111	﹤0.01%	3729
2023 Q2	$660K	Sell	45,465 -639	-1%	-$10.9K	﹤0.01%	3522
2023 Q1	$846K	Hold	46,104	–	–	﹤0.01%	3419
2022 Q4	$677K	Sell	46,104 -895	-2%	-$15.6K	﹤0.01%	3538
2022 Q3	$789K	Sell	46,999 -4,772	-9%	-$105K	﹤0.01%	3513
2022 Q2	$1.22M	Sell	51,771 -1,899	-4%	-$38.2K	﹤0.01%	3337
2022 Q1	$1.25M	Sell	53,670 -3,277	-6%	-$65.3K	﹤0.01%	3512
2021 Q4	$980K	Buy	+56,947	New	+$1.19M	﹤0.01%	3734

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Geode Capital Management's ZIVO Position: Q4 2023 in Review

Geode Capital Management sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 45,475 shares — an estimated $360K sold.

Geode Capital Management first reported a position in ZIVO in Q4 2021 and held it in 8 quarters. The position peaked at $1.25M in Q1 2022. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Geode Capital Management reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Geode Capital Management sold 45,475 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $360K.
Geode Capital Management first reported a position in Zivo Bioscience, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Geode Capital Management's Zivo Bioscience, Inc. Common Stock position peaked at $1.25M in Q1 2022.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.